REQUEST A DEMO
Total
USD $0.00
Search more companies

NanoEnTek Inc. (South Korea)

Main Activities: Analytical Laboratory Instrument Manufacturing
Full name: NanoEnTek Inc. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

NanoenTek, Inc is a company specializing in lab-on-a-chip technology for the life science and diagnostic products industry, focusing on hormone and cardiovascular disease diagnostic items. They have obtained USFDA approval for several medical devices and hold about 100 patents related to nanotechnology, information technology, and biotechnology convergence technology. NanoenTek is dedicated to expanding its global sales and implementing advanced health care environments through technology convergence. They have also sold patents to major global companies and acquired a significant share of the global market for automated cell counters. The company is focused on developing and utilizing advanced technologies in the industry.

Headquarters
12F Ace High End Towers, 235-2 Guro3-Dong, Guro-Gu
Seoul; Seoul; Postal Code: 152-053

Contact Details: Purchase the NanoEnTek Inc. report to view the information.

Website: http://www.nanoentek.com

Basic Information
Total Employees:
Purchase the NanoEnTek Inc. report to view the information.
Outstanding Shares:
Purchase the NanoEnTek Inc. report to view the information.
Registered Capital:
Purchase the NanoEnTek Inc. report to view the information.
Financial Auditors:
Purchase the NanoEnTek Inc. report to view the information.
Incorporation Date:
November 18, 1987
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
9.33%
Purchase this report to view the information.
2.54%
Purchase this report to view the information.
1.74%
Purchase this report to view the information.
0.89%
Purchase this report to view the information.
0.52%
Subsidiaries
Nanoentek America Inc. (United States)
Nanoentek Bio-Technology (Beijing) Ltd (China)
Company Performance
Financial values in the chart are available after NanoEnTek Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
3.52%
Total operating revenue
7.6%
Operating profit (EBIT)
N/A
EBITDA
164.02%
Net Profit (Loss) for the Period
N/A
Total assets
-4.87%
Total equity
-5.68%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.39%
Quick Ratio
-0.12%
Cash Ratio
-1.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?